Clinical trial

High-intensity Focused Ultrasound Combined With Novel Hormone Therapy in Advanced Prostate Cancer

NCT07126093

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

COMBINATION_PRODUCT · Unmapped registry intervention focal high-intensity focused ultrasound therapy combined with standard novel hormonal therapy Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Standard novel hormonal therapy only Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

High-intensity Focused Ultrasound Combined With Novel Hormone Therapy in Advanced Prostate Cancer

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-10-01

PhaseNA

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

focal high-intensity focused ultrasound therapy combined with standard novel hormonal therapyCOMBINATION_PRODUCT

Standard novel hormonal therapy onlyOTHER

Sponsors & collaborators

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicinelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07126093 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.